Molecular Interaction Atlas (MIA) |
|
Indication(s) of Terameprocol |
Disease Entry |
ICD 11 |
Status |
REF |
Solid tumour/cancer |
2A00-2F9Z
|
Phase 2 |
[2] |
|
|
Terameprocol Interacts with 1 DTT Molecule(s)
DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
Transcription factor Sp1 (SP1)
|
TTZEP6S
|
SP1_HUMAN
|
Modulator
|
[2] |
------------------------------------------------------------------------------------ |
|
|
|
|
|
Indication(s) of Doxapram |
Disease Entry |
ICD 11 |
Status |
REF |
Respiratory disease |
CB40
|
Approved |
[3] |
|
|
Doxapram Interacts with 1 DTT Molecule(s)
DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
Peripheral carotid chemoreceptor (PCC)
|
TT6EYVN
|
NOUNIPROTAC
|
Stimulator
|
[4] |
------------------------------------------------------------------------------------ |
|
|
|
|
|
Doxapram Interacts with 2 DME Molecule(s)
DME Name |
DME ID |
UniProt ID |
Mode of Action |
REF |
Cytochrome P450 3A4 (CYP3A4)
|
DE4LYSA
|
CP3A4_HUMAN
|
Metabolism
|
[5] |
Cytochrome P450 3A5 (CYP3A5)
|
DEIBDNY
|
CP3A5_HUMAN
|
Metabolism
|
[5] |
------------------------------------------------------------------------------------ |
|
|
|
|
|
Doxapram Interacts with 1 DOT Molecule(s)
DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
Prolactin (PRL)
|
OTWFQGX7
|
PRL_HUMAN
|
Increases Expression
|
[6] |
------------------------------------------------------------------------------------ |
|
|
|
|
|
|
|
|
|
|
|
|